[BGLC] QoQ Quarter Result on 30-Jun-2022 [#Q2]

Stock
[BGLC] BioNexus Gene Lab Corp.
Announcement Date
15-Aug-2022
Financial Year
2022
Quarter
30-Jun-2022 [#Q2]
Profit Trend
QoQ- -917.65%
YoY- -596.43%
Quarter Report
BGLC's Result
BGLC's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
Revenue 2,377 2,840 2,575 2,485 3,029 3,245 3,576 -23.85%
PBT -53 -127 -67 -140 31 197 370 -
Tax 16 30 10 -2 14 108 75 -64.33%
NP -69 -157 -77 -139 17 89 295 -
Tax Rate - - - - -45.59% -54.72% -20.29% -
Total Cost 2,446 2,997 2,652 2,624 3,012 3,156 3,281 -17.79%
Ratio Analysis
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
NP Margin -2.91 -5.53 -3.01 -5.58 0.56 2.75 8.26 -
Per Share
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
EPS -0.00 -0.01 -0.01 -0.01 0.00 0.01 0.02 -
EPS Diluted -0.00 -0.01 -0.01 -0.01 0.00 0.01 0.02 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.